Literature DB >> 24350645

Tailored Gallium(III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging.

Jakub Simeček1, Ondřej Zemek, Petr Hermann, Johannes Notni, Hans-Jürgen Wester.   

Abstract

The bifunctional chelator NOPO (1,4,7-triazacyclononane-1,4-bis[methylene(hydroxymethyl)phosphinic acid]-7-[methylene(2-carboxyethyl)phosphinic acid]) shows remarkably high Ga(III) complexation efficiency and comprises one carboxylic acid moiety which is not involved into metal ion coordination. An improved synthetic protocol affords NOPO with 45% overall yield. Stepwise protonation constants (log Ka), determined by potentiometry, are 11.96, 5.22, 3.77, and 1.54; the stability constant of the Ga(III) complex is log KGaL = 25.0. Within 5 min, (68)Ga(III) incorporation by NOPO is virtually quantitative at room temperature between pH 3 and 4, and at 95 °C at pH ranging from 0.5 to 7, at NOPO concentrations of 30 μM and 10 μM, respectively. During amide bond formation at the distant carboxylate using the HATU coupling reagent, an intramolecular phosphinic acid ester (phosphilactone) is formed, which is cleaved during (68)Ga complexation or in acidic media, such as trifluoroacetic acid (TFA). Phosphilactone formation can also be suppressed by complexation of Zn(2+) prior to conjugation, the resulting zinc-containing conjugates nevertheless being suitable for direct (68)Ga-labeling. In AR42J (rat pancreatic carcinoma) xenografted CD-1 nude mice, (68)Ga-labeled NOPO-NaI(3)-octreotide conjugate ((68)Ga-NOPO-NOC) showed high and fully blockable tumor uptake (13.9 ± 5% ID/g, 120 min p.i., compared to 0.9 ± 0.4% ID/g with 5 mg/kg of nonlabeled peptide). Uptake in other tissues was generally below 3% ID/g, except appearance of excretion-related activity accumulation in kidneys. NOPO-functionalized compounds tend to be more hydrophilic than the corresponding DOTA- and NODAGA-conjugates, thus promoting fast and extensive renal excretion of (68)Ga-NOPO-radiopharmaceuticals. NOPO-functionalized peptides provide suitable pharmacokinetics in vivo and meet all requirements for efficient (68)Ga-labeling even at room temperature in a kit-like manner.

Entities:  

Keywords:  gallium-68; peptides; phosphinic acid; positron emission tomography; radiopharmaceuticals

Mesh:

Substances:

Year:  2013        PMID: 24350645     DOI: 10.1021/mp400642s

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  11 in total

Review 1.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

2.  Incorporation of gallium-68 into the crystal structure of Prussian blue to form K(68)GaxFe1-x[Fe(CN)6] nanoparticles: toward a novel bimodal PET/MRI imaging agent.

Authors:  Murthi S Kandanapitiye; Matthew D Gott; Andrew Sharits; Silvia S Jurisson; Patrick M Woodward; Songping D Huang
Journal:  Dalton Trans       Date:  2016-05-31       Impact factor: 4.390

3.  Fusarinine C, a novel siderophore-based bifunctional chelator for radiolabeling with Gallium-68.

Authors:  Chuangyan Zhai; Dominik Summer; Christine Rangger; Hubertus Haas; Roland Haubner; Clemens Decristoforo
Journal:  J Labelled Comp Radiopharm       Date:  2015-04-15       Impact factor: 1.921

4.  Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.

Authors:  Alexander Wurzer; Christof Seidl; Alfred Morgenstern; Frank Bruchertseifer; Markus Schwaiger; Hans-Jürgen Wester; Johannes Notni
Journal:  Chemistry       Date:  2017-09-14       Impact factor: 5.236

Review 5.  Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.

Authors:  Irina Velikyan
Journal:  Contrast Media Mol Imaging       Date:  2018-01-04       Impact factor: 3.161

6.  Equilibrium Thermodynamics, Formation, and Dissociation Kinetics of Trivalent Iron and Gallium Complexes of Triazacyclononane-Triphosphinate (TRAP) Chelators: Unraveling the Foundations of Highly Selective Ga-68 Labeling.

Authors:  Adrienn Vágner; Attila Forgács; Ernő Brücher; Imre Tóth; Alessandro Maiocchi; Alexander Wurzer; Hans-Jürgen Wester; Johannes Notni; Zsolt Baranyai
Journal:  Front Chem       Date:  2018-05-23       Impact factor: 5.221

7.  Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6.

Authors:  Stefanie Felicitas Färber; Alexander Wurzer; Florian Reichart; Roswitha Beck; Horst Kessler; Hans-Jürgen Wester; Johannes Notni
Journal:  ACS Omega       Date:  2018-02-28

Review 8.  Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology.

Authors:  Christine Rangger; Roland Haubner
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-30

9.  Click-Chemistry (CuAAC) Trimerization of an αv β6 Integrin Targeting Ga-68-Peptide: Enhanced Contrast for in-Vivo PET Imaging of Human Lung Adenocarcinoma Xenografts.

Authors:  Neil Gerard Quigley; Stefano Tomassi; Francesco Saviero Di Leva; Salvatore Di Maro; Frauke Richter; Katja Steiger; Susanne Kossatz; Luciana Marinelli; Johannes Notni
Journal:  Chembiochem       Date:  2020-06-09       Impact factor: 3.164

10.  Microwave gallium-68 radiochemistry for kinetically stable bis(thiosemicarbazone) complexes: structural investigations and cellular uptake under hypoxia.

Authors:  Israt S Alam; Rory L Arrowsmith; Fernando Cortezon-Tamarit; Frazer Twyman; Gabriele Kociok-Köhn; Stanley W Botchway; Jonathan R Dilworth; Laurence Carroll; Eric O Aboagye; Sofia I Pascu
Journal:  Dalton Trans       Date:  2016-01-07       Impact factor: 4.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.